Observational study on time on treatment with abiraterone and enzalutamide.

by Giuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, Francesco Montorsi, Hans Garmo, Pär Stattin
Published 2020-01-01

Patients’ perspective on prostatic artery embolization: A qualitative study

by Alexander Holm, Hans Lindgren, Mats Bläckberg, Marika Augutis, Peter Jakobsson, Mattias Tell, Jonas Wallinder, Karl-Johan Lundström, Johan Styrke
Published 2021-03-01

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

by Jonathan Parker, Danielle Crawley, Hans Garmo, Hans Garmo, Bertil Lindahl, Johan Styrke, Jan Adolfsson, Mats Lambe, Pär Stattin, Mieke Van Hemelrijck, Kerri Beckmann, Kerri Beckmann
Published 2020-10-01

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

by Walter Cazzaniga, Walter Cazzaniga, Eugenio Ventimiglia, Eugenio Ventimiglia, Massimo Alfano, David Robinson, Ingela Franck Lissbrant, Stefan Carlsson, Stefan Carlsson, Johan Styrke, Francesco Montorsi, Francesco Montorsi, Andrea Salonia, Andrea Salonia, Pär Stattin
Published 2019-03-01

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19)...

by Karin Welén, Anna K Överby, Clas Ahlm, Eva Freyhult, David Robinsson, Anna Jonsson Henningsson, Johan Stranne, Daniel Bremell, Martin Angelin, Elisabeth Lindquist, Robert Buckland, Camilla Thellenberg Carlsson, Karlis Pauksens, Anna Bill-Axelsson, Olof Akre, Cecilia Ryden, Magnus Wagenius, Anders Bjartell, Anna C. Nilsson, Johan Styrke, Johanna Repo, Åse Östholm Balkhed, Katarina Niward, Magnus Gisslén, Andreas Josefsson
Published 2021-03-01